#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Penile cancer Prader-Willi syndrome Non-Hodgkin's lymphoma refractory Chronic hepatitis B Emphysema Angiosarcoma metastatic Cystic fibrosis respiratory infection suppression Uveitis Oesophageal adenocarcinoma Autoimmune myositis Acromegaly Kearns-Sayre syndrome Gastrointestinal stromal tumour Acquired ATTR amyloidosis Blastic plasmacytoid dendritic cell neoplasia More trials…

    Learn about Rare Diseases

    Systemic sclerosis pulmonary – Diagnostics Leiomyosarcoma Marginal zone lymphoma refractory – Diagnostics Haemophilia A without inhibitors – Trials in Disease Krabbe’s disease – Life with Disease Langerhans’ cell histiocytosis – Basic Information Wolfram syndrome – Life with Disease Osteosarcoma metastatic – Basic Information Hereditary optic atrophy – Treatment Familial haemophagocytic lymphohistiocytosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Magnesium Oxybate Recombinant Interferon Beta-1B Phleum Pratense Pollen Extract Etrumadenant Dacomitinib Enalapril Levosimendan Pramipexole Flecainide Acetate Nicotinamide Isaralgagene Civaparvovec Sotrovimab Avacopan Dasiglucagon Mk-2060 Loratadine IPN01195 Annamycin Anhydrous Caffeine Albumin More therapies…

    Learn about Your Condition

    Cerebral haemorrhage Cold urticaria Stevens-Johnson syndrome Cytokine release syndrome T-cell type acute leukaemia Intestinal ischaemia Skin bacterial infection Lower limb fracture Rectal cancer Skin candida Extra-osseous Ewing's sarcoma Bladder cancer stage II Hypereosinophilic syndrome Polycystic liver disease Pulmonary hypertension More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Dedifferentiated liposarcoma

  • Study of Trabectedin alone versus Trabectedin with tTF-NGR combination therapy in adults with metastatic or refractory soft tissue sarcoma who failed first-line treatment

    Recruiting

    3 1 1
    Investigated Drugs:
    • Ttf-Ngr
    Germany

  • Study of Pemigatinib and Retifanlimab for Patients with Advanced Dedifferentiated Liposarcoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Dedifferentiated liposarcoma
    • Liposarcoma
    • Liposarcoma metastatic
    Investigated Drugs:
    • Pemigatinib
    • Retifanlimab
    Denmark Norway Sweden

  • Study on the Effect of Chemotherapy with Ifosfamide, Dacarbazine, and Epirubicin Hydrochloride Before Surgery for Patients with High-Risk Retroperitoneal Sarcoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dacarbazine
    • Epirubicin Hydrochloride
    • Doxorubicin Hydrochloride
    Cyprus Czechia Denmark France Germany Italy +4

  • Study on the Effectiveness and Safety of INT230-6 (Vinblastine Sulfate, Cisplatin) for Adults with Metastatic Soft Tissue Sarcomas

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Dedifferentiated liposarcoma
    • Leiomyosarcoma
    • Myxoid liposarcoma
    Investigated Drugs:
    • Pazopanib
    • Trabectedin
    • Cisplatin
    France Germany Italy Poland Spain

  • Study on Pembrolizumab and Olaparib for Patients with Resectable Soft Tissue Sarcoma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Olaparib
    • Pembrolizumab
    France

  • Study on the Safety and Tolerance of BI 907828 in Patients with Advanced Dedifferentiated Liposarcoma

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dedifferentiated liposarcoma
    Investigated Drugs:
    • (3S,3’S,3A’s,10A’s)-6-Chloro-3′-(3-Chloro-2-Fluorophenyl)-1′-(Cyclopropylmethyl)-6′-Methyl-2-Oxo-1,2,3′,3A’,10′,10A’-Hexahydro-1’H-Spiro[Indole-3,2′-Pyrrolo[2′,3′:4,5]Pyrrolo[1,2-B]Indazole]-7′-Carboxylic Acid
    Belgium Italy

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!